Other workers have demonstrated the role of NADPH oxidase in diabetic retinopathy [36–39], and complications of diabetes [40, 41] including the loss of podocytes in diabetic nephropathy [42]. This evidence concerns the gene FMO5 and diabetic kidney disease.